Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
GE Healthcare
Acusphere licenses ultrasound contrast-related technology rights from GE Healthcare
July 4th, 2006
Acusphere, Inc., (ACUS), announced that it has entered into an agreement to license on a non-exclusive basis various ultrasound-related intellectual property from GE Healthcare, a division of General Electric Company (GE). The agreement provides Acusphere with use of GE's ultrasound contrast agent patents in combination with Acusphere's lead product candidate AI-700 in the field of ultrasound contrast agents, as well as any patents that GE acquires in the field within 12 months of the agreement. The term of this Agreement extends until expiration of the last of the patents licensed under the agreement. Acusphere is developing AI-700, currently in phase III clinical...
Source: Pharma Law Weekly (2006-07-04)
|
